Other new prognostic variables such as ATM, notch receptor 1 (NOTCH1), splicing factor 3b subunit 1 (SF3B1), baculoviral IAP repeat-containing 3 (BIRC3) mutations, may also play a vital role in the management of CLL cases [77,78]. Here, ATM is linked to B-cell chronic lymphocytic leukemia.